Myocardial Infarction
27 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Cardiovascular Diseases, Heart Diseases
Narrower: Anterior Wall Myocardial Infarction 1, Non-ST Elevated Myocardial Infarction 5, Shock, Cardiogenic 1, ST Elevation Myocardial Infarction 10
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Acetylcysteine for st elevation myocardial infarction | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Atorvastatin for myocardial infarction | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Canakinumab for myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cardiovascular Polypill for myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cholecalciferol for myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Clopidogrel for myocardial infarction | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Colchicine for myocardial infarction | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Combined antioxidant therapy for st elevation myocardial infarction | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Direct oral anticoagulant for st elevation myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Evolocumab for non-st elevated myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Evolocumab for st elevation myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Impella 5.5 for shock, cardiogenic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Inclisiran for non-st elevated myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Inclisiran for st elevation myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| PolyPill for non-st elevated myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| PolyPill for st elevation myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Recombinant Human Thymosin Beta 4 Injection (NL005) for anterior wall myocardial infarction | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Recombinant Human Thymosin Beta 4 Injection (NL005) for st elevation myocardial infarction | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Recombinant varicella zoster virus glycoprotein e antigen for myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tenecteplase for st elevation myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ticagrelor for myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ticagrelor for non-st elevated myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ticagrelor for st elevation myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Ticagrelor + placebo for non-st elevated myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ticagrelor + placebo for st elevation myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| VERVE-102 for myocardial infarction | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ziltivekimab for myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.